Literature DB >> 8543019

Interaction of cryptophycin 1 with tubulin and microtubules.

K Kerksiek1, M R Mejillano, R E Schwartz, G I Georg, R H Himes.   

Abstract

The cryptophycins are newly discovered antimitotic agents isolated from the cyanobacterium Nostoc. Previous studies using cultured cells demonstrated that microtubules are the target of these compounds. We have studied the interaction of cryptophycin 1 with tubulin and microtubules in vitro. Cryptophycin 1 is an effective inhibitor of tubulin polymerization, causes tubulin to aggregate, and depolymerizes microtubules to linear polymers somewhat similar to the spiral-like structures produced by the Vinca alkaloids. Cryptophycin 1 also inhibits vinblastine binding to tubulin but not colchicine binding. Thus, it appears that the cryptophycins may bind to the Vinca site in tubulin or to a site that overlaps with the Vinca site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543019     DOI: 10.1016/0014-5793(95)01271-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

2.  Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.

Authors:  Jian Liang; Richard E Moore; Eric D Moher; John E Munroe; Rima S Al-awar; David A Hay; David L Varie; Tony Y Zhang; James A Aikins; Michael J Martinelli; Chuan Shih; James E Ray; Lowell L Gibson; Vasu Vasudevan; Lisa Polin; Kathryn White; Juiwanna Kushner; Chiab Simpson; Susan Pugh; Thomas H Corbett
Journal:  Invest New Drugs       Date:  2005-06       Impact factor: 3.850

3.  Chemoenzymatic synthesis of cryptophycin anticancer agents by an ester bond-forming non-ribosomal peptide synthetase module.

Authors:  Yousong Ding; Christopher M Rath; Kyle L Bolduc; Kristina Håkansson; David H Sherman
Journal:  J Am Chem Soc       Date:  2011-08-25       Impact factor: 15.419

4.  Capturing the essence of organic synthesis: from bioactive natural products to designed molecules in today's medicine.

Authors:  Arun K Ghosh
Journal:  J Org Chem       Date:  2010-10-11       Impact factor: 4.354

Review 5.  Recent Advances in the Synthesis of Marine-Derived Alkaloids via Enzymatic Reactions.

Authors:  Bi-Shuang Chen; Di Zhang; Fayene Zeferino Ribeiro de Souza; Lan Liu
Journal:  Mar Drugs       Date:  2022-05-30       Impact factor: 6.085

6.  Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends.

Authors:  D Panda; K DeLuca; D Williams; M A Jordan; L Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Asymmetric Syntheses of Potent Antitumor Macrolides Cryptophycin B and Arenastatin A.

Authors:  Arun K Ghosh; A Bischoff
Journal:  European J Org Chem       Date:  2004-04-27

8.  Complete Genome Sequence of the Cryptophycin-Producing Cyanobacterium Nostoc sp. Strain ATCC 53789.

Authors:  Anna Tippelt; Tobias Busche; Christian Rückert; Markus Nett
Journal:  Microbiol Resour Announc       Date:  2020-04-02

Review 9.  Marine Cyanobacteria and Microalgae Metabolites-A Rich Source of Potential Anticancer Drugs.

Authors:  Arijit Mondal; Sankhadip Bose; Sabyasachi Banerjee; Jayanta Kumar Patra; Jai Malik; Sudip Kumar Mandal; Kaitlyn L Kilpatrick; Gitishree Das; Rout George Kerry; Carmela Fimognari; Anupam Bishayee
Journal:  Mar Drugs       Date:  2020-09-19       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.